Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges: Pilot Phase
Stopped NIA funded the first phase of the R21. The clinical trial never began as the R33 was not supported.
Conditions
- Fall
- Congestive Heart Failure
- Chronic Kidney Failure
- Adverse Drug Event
Interventions
- BEHAVIORAL: Commitment nudge
- BEHAVIORAL: Justification nudge
Sponsor
RAND
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]